Pregestational diabetes alters cardiac structure and function of neonatal rats through developmental plasticity

Md Jahangir Alam1,2, Shravan Kumar Uppulapu1, Vikas Tiwari1

  • 1Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Guwahati, India.

Insights

Pregnancy with diabetes (PGDM) causes heart problems in newborns. This study maps the molecular and structural changes in neonatal rat hearts exposed to maternal hyperglycemia, revealing pathways for cardiac anomalies.

Area of Science:

  • Developmental Biology
  • Cardiovascular Research
  • Endocrinology

Background:

  • Pregestational diabetes (PGDM) adversely affects fetal development, particularly cardiac function.
  • Maternal hyperglycemia induces cardiac plasticity, including electrical and structural remodeling in offspring.
  • The precise molecular mechanisms underlying PGDM-induced cardiac developmental defects remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular basis of cardiac developmental defects in neonatal rats from mothers with pregestational diabetes.
  • To identify specific molecular pathways and cellular events perturbed in the neonatal heart under hyperglycemic conditions.

Main Methods:

  • Induction of pregestational diabetes in female rats using streptozotocin.
  • Breeding diabetic female rats with healthy male rats.
  • Transcriptomic profiling (RNA-seq) and histopathology of neonatal rat hearts.

Main Results:

  • Neonates from diabetic mothers exhibited altered electrocardiography and echocardiography parameters.
  • Transcriptomic analysis revealed significant changes in genes related to heart development, fibrosis, conduction, and proliferation.
  • Histopathology confirmed focal cardiac fibrosis and increased cell proliferation in affected neonates.

Conclusions:

  • Pregestational diabetes perturbs critical molecular pathways and cellular events during neonatal heart development.
  • These perturbations contribute to cardiac anomalies and functional deficits observed in offspring of diabetic mothers.
  • The study provides a comprehensive molecular map of cardiac developmental plasticity alterations in response to maternal hyperglycemia.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K